The Journal of Allergy and Clinical Immunology
Volume 104, Issue 2 , Pages 267-270 , August 1999

Sublingual immunotherapy

Received 28 April 1999

References 

  1. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma: a meta-analysis of randomized controlled trials. Am J Respir Crit Care Med. 1995;151:969–974
  2. British Society for Allergy and Clinical Immunology . Injection immunotherapy. Clin Exp Allergy. 1993;23(3 Suppl):1–44
  3. Des Roches A, Paradis L, Knani J, Hejjaoui A, Dhivert H, Chanez P, et al.  Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, V: duration of the efficacy of immunotherapy after its cessation. Allergy. 1996;51:430–433
  4. Jacobsen L, Nüchel Petersen B, Wihl JA, Lowenstein H, Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts, IV: results of long term follow-up. Allergy. 1997;52:914–920
  5. Bousquet J, Hejjaoui A, Michel FB. Specific immunotherapy in asthma. J Allergy Clin Immunol. 1990;86:292–305
  6. Creticos PS, Reed CE, Norman PS, Khoury J, Adkinson NF, Buncher CR, et al.  Ragweed immunotherapy in adult asthma. N Engl J Med. 1996;334:501–506
  7. Ohman JL. Allergen immunotherapy in asthma: evidence for efficacy. J Allergy Clin Immunol. 1989;84:133–139
  8. Committee on the Safety of Medicines . CSM update: immunotherapy. BMJ. 1986;293:948
  9. Lilja G, Sundin B, Graff-Lonnevig V, Hedin G, Heilborn H, Norrlind K, et al.  Immunotherapy with partially purified and standardized animal dander extracts, IV: effects of 2 years of treatment. J Allergy Clin Immunol. 1989;83:37–44
  10. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by anti-allergic drugs. BMJ. 1991;302:265–269
  11. Löfkvist T, Agrell B, Dreborg S, Svensson G. Effects of immunotherapy with a purified standardized allergen preparation of Dermatophagoides farinae in adults with perennial allergic rhinoconjunctivitis. Allergy. 1994;49:100–107
  12. Peroni DG, Piacentini GL, Martinati LC, Warner JO, Boner AL. Double-blind trial of house dust mite immunotherapy in asthmatic children resident at high altitude. Allergy. 1995;50:925–930
  13. Olaguibel JM, Tabar AI, Garcia Fuguera BE, Cortes C. Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: a dose titration study. Allergy. 1997;52:168–178
  14. Pichler CE, Marquardson A, Sparholt S, Lowenstein H, Bircher A, Bischof M, et al.  Specific immunotherapy with Dermatophagoides pteronyssinus and D farinae results in reduced bronchial hyperreactivity. Allergy. 1997;52:274–283
  15. Olsen OT, Larsen KR, Jacobsen L, Svendsen UG. A one year placebo-controlled double-blind house dust mite immunotherapy study in asthmatic adults. Allergy. 1997;52:853–859
  16. Varney VA, Edwards J, Tabbah K, Brewster H, Mavroleon G, Frew AJ. Clinical efficacy of specific immunotherapy to cat dander: a double blind placebo controlled trial. Clin Exp Allergy. 1997;27:860–867
  17. Lockey RF, Benedict L, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol. 1987;79:660–667
  18. Reid MJ, Lockey RF, Turkeltaub PC, PLatts-Mills TAE. Fatalities from immunotherapy and skin testing [abstract]. J Allergy Clin Immunol. 1990;85:180
  19. Reid MJ, Lockey RF, Turkeltaub PC, PLatts-Mills TAE, Lehrer SB. Fatalities from immunotherapy 1990-91 [abstract 823]. J Allergy Clin Immunol. 1992;89:
  20. Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, VI: specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol. 1997;99:450–453
  21. Wheeler AW, Drachenberg KJ. New routes and formulations for allergen-specific immunotherapy. Allergy. 1997;52:602–612
  22. McHugh SM, Deighton J, Stewart AG, Lachman PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a Th2 to a Th1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy. 1995;25:828–838
  23. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al.  Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T-lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing mRNA for interferon-gamma. J Allergy Clin Immunol. 1996;97:1356–1365
  24. Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, et al.  Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from Th2 to Th1 in T-cell clones specific for Phl p1, a major grass pollen allergen. Clin Exp Allergy. 1997;27:1007–1015
  25. Hamid QA, Schotman E, Jacobson M, Walker S, Durham SR. Increases in IL-12 mRNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol. 1997;99:254–260
  26. Norman PS, Ohman JL, Long AA, Creticos PS, Gefter MA, Shaked Z, et al.  Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med. 1996;154:1623–1628
  27. Muller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, et al.  Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol. 1998;101:747–754
  28. Hsu CH, Chua KY, Tao MH, Lai YL, Wu HD, Huang SK, et al.  Immunoprophylaxis of allergen-induced IgE synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nature Med. 1996;2:540–544
  29. Spiegelberg H, Orozco EM, Roman M, Raz E. DNA immunization: a novel approach to allergen-specific immunotherapy. Allergy. 1997;52:964–970
  30. Ortolani C, Pastorello EA, Incorvaia C, Ispano M, Farioli L, Zara C, et al.  A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever. Allergy. 1994;49:13–21
  31. Tari MG, Mancino M, Ghezzi E, Frank E, Cromwell O. Immunotherapy with an alum-adsorbed Parietaria -pollen allergoid: a 2-year double blind placebo controlled study. Allergy. 1997;52:65–74
  32. Andri L, Senna G, Betteli C, Givanni S, Andri G, Dimitri G, et al.  Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double blind study. J Allergy Clin Immunol. 1996;97:34–41
  33. Andri L, Senna G, Betteli C, Givanni S, Andri G, Falagiani P. Local nasal immunotherapy for Dermatophagoides-induced rhinitis: efficacy of a powder extract. J Allergy Clin Immunol. 1993;91:987–996
  34. Giovane AL, Bardare M, Passalacqua G, Ruffoni S, Scordamaglia A, Ghezzi E, et al.  A three year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. Clin Exp Allergy. 1994;24:53–59
  35. Litwin A, Flanagan M, Entis G, Gottschieb G, Esch R, Gartside P, et al.  Oral immunotherapy with short ragweed extract in a novel encapsulated preparation: a double-blind study. J Allergy Clin Immunol. 1997;100:30–38
  36. Oppenheimer J, Areson JG, Nelson HS. Safety and efficacy of oral immunotherapy with standardized cat extract. J Allergy Clin Immunol. 1994;93:61–67
  37. Sabbah A, Hassoun S, Le Sellin J, Andre C, Sicard H. A double-blind, placebo-controlled trials by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy. 1994;49:309–313
  38. Leng X, Fu YX, Ye ST, Duan SQ. A double-blind trial of oral immunotherapy for Artemisia pollen asthma with evaluation of bronchial response to the pollen allergen and serum-specific IgE antibody. Ann Allergy. 1990;64:27–31
  39. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mites: a double-blind study. Allergol Immunopathol. 1990;18:277–284
  40. Feliziani V, Lattuada G, Partmiani S, Dall’aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts: a double-blind study. Allergol Immunopathol. 1995;23:224–230
  41. Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen–induced rhinitis: a double-blind study. J Invest Allergol Clin Immunol. 1995;5:25–30
  42. Clavel R, Bousquet J, Andre C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind placebo-controlled trial of a standardised five-grass-pollen extract in rhinitis. Allergy. 1998;53:493–498
  43. Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB, et al.  Sublingual-swallow immunotherapy in patients with asthma due to house dust mites: a double-blind, placebo-controlled study. Allergy. 1999;54:249–260
  44. Fell P, Brostoff J. A single dose desensitization for summer hay fever. Eur J Clin Pharmacol. 1990;38:77–79
  45. Reilly DT, Taylor MA, McSharry C, Aitchison T. Is homeopathy a placebo response: controlled trial of homeopathic potency with pollen in hay fever as a model. Lancet. 1986;2:881–886
  46. Bousquet J, Lockey RF, Malling HJ. WHO position paper, allergen immunotherapy: therapeutic vaccines for allergic disease. Allergy. 1998;53(44 Suppl):1–42
  47. La Rosa M, Ranno C, Andre C, Carat F, Tosca A, Canonica GW. Double-blind placebo-controlled evaluation of sublingualswallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol. 1999;104:425–432

☆ Reprint requests: A. J. Frew, MD, FRCP, University Medicine (810), Southampton General Hospital, Southampton SO16 6YD, United Kingdom.

☆☆ J Allergy Clin Immunol 1999;104:267-70.

★ 0091-6749/99 $8.00 + 0  1/1/99864

PII: S0091-6749(99)70362-3

The Journal of Allergy and Clinical Immunology
Volume 104, Issue 2 , Pages 267-270 , August 1999

Article Tools